Gsk Plc Stock Performance
| GLAXF Stock | USD 25.87 0.88 3.52% |
On a scale of 0 to 100, GSK Plc holds a performance score of 6. The company retains a Market Volatility (i.e., Beta) of -0.63, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning GSK Plc are expected to decrease at a much lower rate. During the bear market, GSK Plc is likely to outperform the market. Please check GSK Plc's total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether GSK Plc's current trending patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in GSK plc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, GSK Plc reported solid returns over the last few months and may actually be approaching a breakup point. ...more
GSK |
GSK Plc Relative Risk vs. Return Landscape
If you would invest 2,274 in GSK plc on November 1, 2025 and sell it today you would earn a total of 313.00 from holding GSK plc or generate 13.76% return on investment over 90 days. GSK plc is currently producing 0.2726% returns and takes up 3.418% volatility of returns over 90 trading days. Put another way, 30% of traded pink sheets are less volatile than GSK, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
GSK Plc Target Price Odds to finish over Current Price
The tendency of GSK Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 25.87 | 90 days | 25.87 | roughly 2.56 |
Based on a normal probability distribution, the odds of GSK Plc to move above the current price in 90 days from now is roughly 2.56 (This GSK plc probability density function shows the probability of GSK Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon GSK plc has a beta of -0.63. This usually indicates as returns on the benchmark increase, returns on holding GSK Plc are expected to decrease at a much lower rate. During a bear market, however, GSK plc is likely to outperform the market. Additionally GSK plc has an alpha of 0.3594, implying that it can generate a 0.36 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). GSK Plc Price Density |
| Price |
Predictive Modules for GSK Plc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GSK plc. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GSK Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GSK Plc Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. GSK Plc is not an exception. The market had few large corrections towards the GSK Plc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold GSK plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of GSK Plc within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.36 | |
β | Beta against Dow Jones | -0.63 | |
σ | Overall volatility | 1.21 | |
Ir | Information ratio | 0.08 |
GSK Plc Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GSK Plc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GSK plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| GSK plc had very high historical volatility over the last 90 days |
GSK Plc Fundamentals Growth
GSK Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of GSK Plc, and GSK Plc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GSK Pink Sheet performance.
| Return On Equity | 0.31 | |||
| Return On Asset | 0.0659 | |||
| Profit Margin | 0.51 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 90.86 B | |||
| Shares Outstanding | 4.09 B | |||
| Price To Earning | 11.44 X | |||
| Price To Book | 6.49 X | |||
| Price To Sales | 1.91 X | |||
| Revenue | 29.32 B | |||
| EBITDA | 8.8 B | |||
| Cash And Equivalents | 6.53 B | |||
| Cash Per Share | 1.62 X | |||
| Total Debt | 19.76 B | |||
| Debt To Equity | 0.98 % | |||
| Book Value Per Share | 2.63 X | |||
| Cash Flow From Operations | 7.4 B | |||
| Earnings Per Share | 1.32 X | |||
| Total Asset | 60.15 B | |||
| Retained Earnings | (6.55 B) | |||
| Current Asset | 17.61 B | |||
| Current Liabilities | 18.14 B | |||
About GSK Plc Performance
By analyzing GSK Plc's fundamental ratios, stakeholders can gain valuable insights into GSK Plc's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if GSK Plc has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GSK Plc has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.Things to note about GSK plc performance evaluation
Checking the ongoing alerts about GSK Plc for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for GSK plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GSK plc had very high historical volatility over the last 90 days |
- Analyzing GSK Plc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GSK Plc's stock is overvalued or undervalued compared to its peers.
- Examining GSK Plc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GSK Plc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of GSK Plc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GSK Plc's pink sheet. These opinions can provide insight into GSK Plc's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for GSK Pink Sheet analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |